European Commission: Netherlands receives experimental hantavirus drug

The European Commission announced that the Netherlands will receive the first doses of Favipiravir, an experimental antiviral drug for treating hantavirus. While no treatment is currently approved, the European Medicines Agency has deemed the drug suitable for use in clinical trials.